28.24 (0.03%)
As of Aug 09, 2022
Source:
Intersect Ent, Inc is a global ear, nose and throat (“ENT”) medical technology leader dedicated to transforming patient care. Our U.S. Food and Drug Administration (“FDA”) approved steroid releasing products are designed to provide mechanical spacing and deliver targeted therapy (mometasone furoate) to the site of disease.
Country | United States |
Headquarters | menlo park, california |
Phone Number | 650-641-2100 |
Industry | manufacturing |
CEO | Thomas A. West |
Website | intersectent.com |